The role of surgery in integrated therapies for non-small-cell lung cancer

F. Sartori, L. Bortolotti, M. Michelon, F. Colaut, M. Loy, F. Rea, A. Favaretto

Research output: Contribution to journalArticle

Abstract

Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selected cases, even locally-advanced cancers may be suitable for surgical treatment. The combination of chemotherapy (with or without radiotherapy) and surgery has proved potentially useful in improving survival, but pre-operative treatment may represent a risk factor for the onset of post-operative complications. Studies performed to date indicate the need for further multidisciplinary research with a view to identifying more advantageous treatment modalities, particularly for locally-advanced NSCLC.

Original languageEnglish
JournalAnnals of Oncology
Volume10
Issue numberSUPPL. 5
Publication statusPublished - 1999

Keywords

  • Combined modalities
  • Non-small-lung cancer
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The role of surgery in integrated therapies for non-small-cell lung cancer'. Together they form a unique fingerprint.

  • Cite this

    Sartori, F., Bortolotti, L., Michelon, M., Colaut, F., Loy, M., Rea, F., & Favaretto, A. (1999). The role of surgery in integrated therapies for non-small-cell lung cancer. Annals of Oncology, 10(SUPPL. 5).